Skip to main content
Log in

Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Changes in the blood lipid spectrum and structural reorganization of the rat myocardium in response to injection of a single sublethal dose of doxorubicin (7 mg/kg) alone and in combination with course administration of betulonic acid amide (100 mg/kg/day for 14 days) were studied. Betulinic acid amide in the specified dose exhibited less pronounced cardiotoxic (necrobiotic impairment of cardiomyocytes) and dyslipidemic (increase of cholesterol and triglyceride levels) effects in comparison with doxorubicin. Combined treatment with betulinic acid amide and doxorubicin led to more pronounced remodeling of the myocardium, which was shown by a significant increase of the connective tissue/cardiomyocyte volume ratio detected by day 14 of the experiment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Klinnikova MG, Yuzhik EI, Pichigin VI, Lushnikova EL. Remodeling of myocardium in rat with chronic dyslipidemia and under conditions of verapamil treatment. Bull. Exp. Biol. Med. 2014;158(1):97-103.

    Article  CAS  PubMed  Google Scholar 

  2. Lushnikova EL, Klinnikova MG, Molodykh OP, Nepomnyashchikh LM. Morphological manifestations of heart remodeling in anthracyclinee-induced dilated cardiomyopathy. Bull. Exp. Biol. Med. 2004;138(6):607-612.

    Article  CAS  PubMed  Google Scholar 

  3. Lushnikova EL, Nepomnyashchikh LM, Molodykh NA, Klinnikova MG, Molodykh OP. Effect of doxorubicin and triterpenoids on structural reorganization of rat myocardium and the number of cardiomyocytes. Fundamental. Issled. 2011;(6):98-102. Russian.

  4. Nepomnyashchikh LM. Regenerative and plastic heart failure: molecular biological mechanisms and morphological bases. Arkh. Patol. 2007;69(3):3-12. Russian.

  5. Tolstikova TG, Sorokina IV, Tolstikov GA, Tolstikov AG, Flekhter OB. Biological activity and pharmacological prospects of lupane terpenoids: II. Semisynthetic lupane derivatives. Rus. J. Bioorgan. Chem. 2006;32(3):261-276.

    Article  CAS  Google Scholar 

  6. Castellano JM, Guinda A, Delgado T, Rada M, Cayuela JA. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes. 2013;62(6):1791-1799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chudzik M, Korzonek-Szlacheta I, Król W. Triterpenes as potentially cytotoxic compounds. Molecules. 2015;20(1):1610-1625.

    Article  PubMed  Google Scholar 

  8. De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A, Berrino L, Ferreira-Martins J, Zheng H, Hosoda T, Rota M, Urbanek K, Kajstura J, Leri A, Rossi F, Anversa P. Anthracyclinee cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation. 2010;121(2):276-292.

    Article  PubMed  Google Scholar 

  9. Fulda S. Betulinic acid: a natural product with anticancer activity. Mol. Nutr. Food Res. 2009;53(1):140-146.

    Article  CAS  PubMed  Google Scholar 

  10. Horenstein MS, Vander Heide RS, L’Ecuyer TJ. Molecular basis of anthracyclinee-induced cardiotoxicity and its prevention. Mol. Genet. Metab. 2000;71(1-2):436-444.

    Article  CAS  PubMed  Google Scholar 

  11. Huang TH, Yang Q, Harada M, Uberai J, Radford J, Li G.Q, Yamahara J, Roufogalis BD, Li Y. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes. Toxicol. Appl. Pharmacol. 2006;210 (1-2):78-85.

    Article  CAS  PubMed  Google Scholar 

  12. Liby K, Honda T, Williams CR, Risingsong R, Royce DB, Suh N, Dinkova-Kostova AT, Stephenson KK, Talalay P, Sundararajan C, Gribble GW, Sporn MB. Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities. Mol. Cancer Ther. 2007;6(7):2113-2119.

    Article  CAS  PubMed  Google Scholar 

  13. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclinees: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharm. Rev. 2004;56(2):185-229.

    Article  CAS  PubMed  Google Scholar 

  14. Sporn MB, Liby K, Yore MM, Suh N, Albini A, Honda T, Sundararajan C, Gribble GW. Platforms and networks in triterpenoid pharmacology. Drug Develop. Res. 2007;68(4):174-182. doi/10.1002/ddr.v68:4/issuetoc.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. G. Klinnikova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 8, pp. 247-252, August, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klinnikova, M.G., Lushnikova, E.L., Koldysheva, E.V. et al. Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide. Bull Exp Biol Med 162, 277–282 (2016). https://doi.org/10.1007/s10517-016-3594-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-016-3594-9

Key Words

Navigation